A new version of this entry is available:
Loading...
Article
2024
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics
Abstract (English)
Background: Cancer cachexia (CCx) presents a multifaceted challenge characterized by negative protein and energy balance and systemic inflammatory response activation. While previous CCx studies predominantly focused on mouse models or human body fluids, there's an unmet need to elucidate the molecular inter-organ cross-talk underlying the pathophysiology of human CCx. Methods: Spatial metabolomics were conducted on liver, skeletal muscle, subcutaneous and visceral adipose tissue, and serum from cachectic and control cancer patients. Organ-wise comparisons were performed using component, pathway enrichment and correlation network analyses. Inter-organ correlations in CCx altered pathways were assessed using Circos. Machine learning on tissues and serum established classifiers as potential diagnostic biomarkers for CCx. Results: Distinct metabolic pathway alteration was detected in CCx, with adipose tissues and liver displaying the most significant (P ≤ 0.05) metabolic disturbances. CCx patients exhibited increased metabolic activity in visceral and subcutaneous adipose tissues and liver, contrasting with decreased activity in muscle and serum compared to control patients. Carbohydrate, lipid, amino acid, and vitamin metabolism emerged as highly interacting pathways across different organ systems in CCx. Muscle tissue showed decreased (P ≤ 0.001) energy charge in CCx patients, while liver and adipose tissues displayed increased energy charge (P ≤ 0.001). We stratified CCx patients by severity and metabolic changes, finding that visceral adipose tissue is most affected, especially in cases of severe cachexia. Morphometric analysis showed smaller (P ≤ 0.05) adipocyte size in visceral adipose tissue, indicating catabolic processes. We developed tissue-based classifiers for cancer cachexia specific to individual organs, facilitating the transfer of patient serum as minimally invasive diagnostic markers of CCx in the constitution of the organs. Conclusions: These findings support the concept of CCx as a multi-organ syndrome with diverse metabolic alterations, providing insights into the pathophysiology and organ cross-talk of human CCx. This study pioneers spatial metabolomics for CCx, demonstrating the feasibility of distinguishing cachexia status at the organ level using serum.
File is subject to an embargo until
This is a correction to:
A correction to this entry is available:
This is a new version of:
Other version
Notes
Publication license
Publication series
Published in
Metabolism, 161 (2024), 156034.
https://doi.org/10.1016/j.metabol.2024.156034.
ISSN: 1532-8600
Other version
Faculty
Institute
Examination date
Supervisor
Cite this publication
Sun, N., Krauss, T., Seeliger, C., Kunzke, T., Stöckl, B., Feuchtinger, A., Zhang, C., Voss, A., Heisz, S., Prokopchuk, O., Martignoni, M. E., Janssen, K.-P., Claussnitzer, M., Hauner, H., & Walch, A. (2024). Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics. Metabolism, 161. https://doi.org/10.1016/j.metabol.2024.156034
Edition / version
Citation
DOI
ISSN
ISBN
Language
English
Publisher
Publisher place
Classification (DDC)
610 Medicine and health
Collections
Original object
University bibliography
Standardized keywords (GND)
Sustainable Development Goals
BibTeX
@article{Sun2024,
url = {https://hohpublica.uni-hohenheim.de/handle/123456789/18068},
doi = {10.1016/j.metabol.2024.156034},
author = {Sun, Na and Krauss, Tanja and Seeliger, Claudine et al.},
title = {Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics},
journal = {Metabolism},
year = {2024},
volume = {161},
}